Oncology

RadiaDyne Receives Clearance for Two Additional FDA Indications for the OARtrac System

No comments
RadiaDyne Receives Clearance for Two Additional FDA Indications for the OARtrac System

With these added indications, Physicians can now use OARtracĀ® to routinely monitor brachytherapy radiation dose in certain anatomies, as well as reuse the proprietary OARtracĀ® PSD (Plastic Scintillating Detector) sensor cable up to five times on the same patient.

iData ResearchRadiaDyne Receives Clearance for Two Additional FDA Indications for the OARtrac System
read more